Clinical Trials Browser

Phase 1 × BI 2536 × Tumor-Agnostic × Clear all

NCT02211859 2024-12-20

Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit

Phase 1 Completed

Neoplasms